Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma.

ESMO Open
S AeppliC Rothermundt

Abstract

The coronavirus pandemic has provoked discussions among healthcare providers how to manage cancer patients when faced with the threat of severe acute respiratory syndrome related coronavirus 2 (SARS-CoV-2) infection. Immune checkpoint inhibitor (ICI) containing regimens are standard of care in the majority of metastatic clear cell renal cell carcinoma (mccRCC) patients. It remains unclear whether therapies should be modified in response to the COVID-19 pandemic. We performed an online survey among physicians involved in the treatment of mccRCC, and 41 experts responded. Questions focused on criteria relevant for treatment decision outside the pandemic and the modifications of systemic therapy during COVID-19. For the majority of experts (73%), the combination of International metastatic renal cell carcinoma Database Consortium (IMDC) risk category and patient fitness are two important factors for decision-making. The main treatment choice in fit, favourable risk patients outside the pandemic is pembrolizumab/axitinib for 53%, avelumab/axitinib, sunitinib or pazopanib for 13% of experts each. During the pandemic, ICI-containing regimens are chosen less often in favour of a tyrosine kinase inhibitors (TKI) monotherapy, mainly sun...Continue Reading

References

Jan 12, 2007·The New England Journal of Medicine·Robert J MotzerRobert A Figlin
Jun 1, 2007·The New England Journal of Medicine·Gary HudesUNKNOWN Global ARCC Trial
Jan 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cora N SternbergRobert E Hawkins
Sep 11, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerThomas E Hutson
Feb 16, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Toni K ChoueiriMichael J Morris
Mar 22, 2018·The New England Journal of Medicine·Robert J MotzerUNKNOWN CheckMate 214 Investigators
Feb 20, 2019·The New England Journal of Medicine·Robert J MotzerToni K Choueiri
Feb 23, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B EscudierUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Jul 3, 2019·Frontiers in Cellular and Infection Microbiology·Günther Schönrich, Martin J Raftery
Nov 7, 2019·Journal of the National Comprehensive Cancer Network : JNCCN·Robert J MotzerGriselda Zuccarino-Catania
Jan 29, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B EscudierUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Feb 19, 2020·The Lancet Oncology·Wenhua LiangJianxing He
Mar 24, 2020·The New England Journal of Medicine·Robert D TruogGeorge Q Daley
Mar 24, 2020·JAMA : the Journal of the American Medical Association·Graziano OnderSilvio Brusaferro
Apr 1, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L ZhangM Zhou
Apr 9, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen A CannistraKarla Ballman
Apr 11, 2020·JAMA : the Journal of the American Medical Association·An PanTangchun Wu
Apr 14, 2020·The New England Journal of Medicine·Adam J SingerMark C Henry
Jun 11, 2020·BMJ : British Medical Journal·Jacqui Wise

❮ Previous
Next ❯

Citations

Jan 23, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Cengiz KaracinMutlu Dogan
Nov 15, 2020·Journal of Clinical Medicine·Sebastian KrugJörg Schrader
Jan 17, 2021·Urologic Oncology·Shuchi GulatiSumanta K Pal

❮ Previous
Next ❯

Software Mentioned

ESMO
CoCARE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.